LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 (Inhaled Sirolimus) in Adults with Sarcoidosis Associated Pulmonary Hypertension (SAPH)
Epistemonikos ID: 27b46728c9a8489525d2b31f1a951294157afa8c
First added on: Oct 22, 2026